Jan Broekroelofs

544 total citations
14 papers, 421 citations indexed

About

Jan Broekroelofs is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Transplantation. According to data from OpenAlex, Jan Broekroelofs has authored 14 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Transplantation. Recurrent topics in Jan Broekroelofs's work include Renal Transplantation Outcomes and Treatments (5 papers), Vasculitis and related conditions (5 papers) and Transplantation: Methods and Outcomes (4 papers). Jan Broekroelofs is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), Vasculitis and related conditions (5 papers) and Transplantation: Methods and Outcomes (4 papers). Jan Broekroelofs collaborates with scholars based in Netherlands, Canada and Pakistan. Jan Broekroelofs's co-authors include Coen A. Stegeman, A. H. L. Mulder, Paul E. de Jong, G.F. Nelis, Dick de Zeeuw, Wim van der Bij, W.J. de Boer, Cees G. M. Kallenberg, Gerda Horst and P. C. Limburg and has published in prestigious journals such as The Lancet, Journal of the American Society of Nephrology and Transplantation.

In The Last Decade

Jan Broekroelofs

13 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Broekroelofs Netherlands	10	178	144	115	86	76	14	421
BF Murphy Australia	9	135 0.8×	99 0.7×	57 0.5×	260 3.0×	34 0.4×	9	414
Wolfgang Grotz Germany	11	139 0.8×	114 0.8×	142 1.2×	292 3.4×	24 0.3×	18	811
A Vangelista Italy	14	122 0.7×	112 0.8×	100 0.9×	261 3.0×	85 1.1×	58	501
Barbara Infante Italy	10	64 0.4×	107 0.7×	135 1.2×	130 1.5×	31 0.4×	16	431
B Parchoux France	8	108 0.6×	37 0.3×	101 0.9×	216 2.5×	35 0.5×	27	385
Mario F. Rubin United States	9	141 0.8×	48 0.3×	35 0.3×	102 1.2×	54 0.7×	14	381
Henk Boom Netherlands	9	126 0.7×	275 1.9×	284 2.5×	111 1.3×	27 0.4×	18	522
Kaan Gülleroğlu Türkiye	12	100 0.6×	145 1.0×	64 0.6×	136 1.6×	125 1.6×	58	438
Kakit Chan United Kingdom	8	75 0.4×	80 0.6×	133 1.2×	101 1.2×	29 0.4×	9	488
Tuula Hölttä Finland	13	123 0.7×	56 0.4×	24 0.2×	231 2.7×	49 0.6×	18	338

Countries citing papers authored by Jan Broekroelofs

Since Specialization

Citations

This map shows the geographic impact of Jan Broekroelofs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Broekroelofs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Broekroelofs more than expected).

Fields of papers citing papers by Jan Broekroelofs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Broekroelofs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Broekroelofs. The network helps show where Jan Broekroelofs may publish in the future.

Co-authorship network of co-authors of Jan Broekroelofs

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Broekroelofs. A scholar is included among the top collaborators of Jan Broekroelofs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Broekroelofs. Jan Broekroelofs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Morel, Chantal F., Mark Eijgelsheim, Margriet F. C. de Jong, et al.. (2022). Fabry disease with atypical phenotype identified by massively parallel sequencing in early-onset kidney failure. Clinical Kidney Journal. 16(4). 722–726. 2 indexed citations

Stassen, Patricia M., Jan Broekroelofs, Pieter van Paassen, et al.. (2019). Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Clinical Journal of the American Society of Nephrology. 14(7). 1021–1028. 38 indexed citations

Sanders, Jan‐Stephan, Anoek A. E. de Joode, Jan Broekroelofs, et al.. (2016). Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial. Nephrology Dialysis Transplantation. 31(9). 1453–1459. 48 indexed citations

Broekroelofs, Jan, et al.. (2004). Valproic acid intoxication: sense and non-sense of haemodialysis.. PubMed. 62(9). 333–6. 25 indexed citations

Broekroelofs, Jan, Gerjan Navis, Coen A. Stegeman, et al.. (2000). LONG-TERM RENAL OUTCOME AFTER LUNG TRANSPLANTATION IS PREDICTED BY THE 1-MONTH POSTOPERATIVE RENAL FUNCTION LOSS. Transplantation. 69(8). 1624–1628. 56 indexed citations

Broekroelofs, Jan, Coen A. Stegeman, Gerjan Navis, et al.. (2000). Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable?. The Journal of Heart and Lung Transplantation. 19(3). 256–262. 35 indexed citations

Broekroelofs, Jan, Coen A. Stegeman, Gerjan Navis, & Paul E. de Jong. (1999). Prevention of renal function loss after non-renal solid organ transplantation—how can nephrologists help to keep the kidneys out of the line of fire?. Nephrology Dialysis Transplantation. 14(8). 1841–1843. 9 indexed citations

Broekroelofs, Jan, Coen A. Stegeman, Wim van der Bij, Paul E. de Jong, & Gerjan Navis. (1998). Renal failure after lung transplantation. The Lancet. 352(9121). 69–70. 1 indexed citations

Broekroelofs, Jan, Coen A. Stegeman, GJ Navis, et al.. (1998). Risk factors for long-term renal survival after renal transplantation. Journal of the American Society of Nephrology. 9(11). 2075–2081. 42 indexed citations

10.

Navis, Gerjan, et al.. (1996). RENAL HEMODYNAMICS AFTER LUNG TRANSPLANTATION. Transplantation. 61(11). 1600–1605. 32 indexed citations

11.

Stegeman, Coen A., et al.. (1996). Differential diagnosis of early graft dysfunction by urinary excretion of alpha- and pi-glutathione-S-transferase (GST) in renal transplantation (RT). Data Archiving and Networked Services (DANS). 7(9). 1 indexed citations

12.

Broekroelofs, Jan, et al.. (1994). Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Digestive Diseases and Sciences. 39(3). 545–549. 52 indexed citations

13.

Mulder, A. H. L., Jan Broekroelofs, Gerda Horst, et al.. (1994). Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clinical & Experimental Immunology. 95(3). 490–497. 69 indexed citations

14.

Mulder, A. H. L., et al.. (1993). Antineutrophil Antibodies in Inlammatory Bowel Disease Recognize Different Antigens. Advances in experimental medicine and biology. 336. 519–522. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact